Unicycive Therapeutics, Inc. (NASDAQ: UNCY) reported Q1 EPS of ($0.61), $0.51 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Unicycive Therapeutics, Inc. (UNCY) click here.